• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GEP100将表皮生长因子受体信号传导与Arf6激活相联系,以诱导乳腺癌侵袭。

GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion.

作者信息

Morishige Masaki, Hashimoto Shigeru, Ogawa Eiji, Toda Yoshinobu, Kotani Hirokazu, Hirose Mayumi, Wei Shumei, Hashimoto Ari, Yamada Atsuko, Yano Hajime, Mazaki Yuichi, Kodama Hiroshi, Nio Yoshinori, Manabe Toshiaki, Wada Hiromi, Kobayashi Hidenori, Sabe Hisataka

机构信息

Department of Molecular Biology, Osaka Bioscience Institute, Osaka 565-0874, Japan.

出版信息

Nat Cell Biol. 2008 Jan;10(1):85-92. doi: 10.1038/ncb1672. Epub 2007 Dec 16.

DOI:10.1038/ncb1672
PMID:18084281
Abstract

Epidermal growth factor (EGF) receptor (EGFR) signalling is implicated in tumour invasion and metastasis. However, whether there are EGFR signalling pathways specifically used for tumour invasion still remains elusive. Overexpression of Arf6 and its effector, AMAP1, correlates with and is crucial for the invasive phenotypes of different breast cancer cells. Here we identify the mechanism by which Arf6 is activated to induce tumour invasion. We found that GEP100/BRAG2, a guanine nucleotide exchanging factor (GEF) for Arf6, is responsible for the invasive activity of MDA-MB-231 breast cancer cells, whereas the other ArfGEFs are not. GEP100, through its pleckstrin homology domain, bound directly to Tyr1068/1086-phosphorylated EGFR to activate Arf6. Overexpression of GEP100, together with Arf6, caused non-invasive MCF7 cells to become invasive, which was dependent on EGF stimulation. Moreover, GEP100 knockdown blocked tumour metastasis. GEP100 was expressed in 70% of primary breast ductal carcinomas, and was preferentially co-expressed with EGFR in the malignant cases. Our results indicate that GEP100 links EGFR signalling to Arf6 activation to induce invasive activities of some breast cancer cells, and hence may contribute to their metastasis and malignancy.

摘要

表皮生长因子(EGF)受体(EGFR)信号传导与肿瘤侵袭和转移有关。然而,是否存在专门用于肿瘤侵袭的EGFR信号通路仍不清楚。Arf6及其效应器AMAP1的过表达与不同乳腺癌细胞的侵袭表型相关且至关重要。在此,我们确定了Arf6被激活以诱导肿瘤侵袭的机制。我们发现,Arf6的鸟嘌呤核苷酸交换因子(GEF)GEP100/BRAG2负责MDA-MB-231乳腺癌细胞的侵袭活性,而其他ArfGEF则不然。GEP100通过其普列克底物蛋白同源结构域直接结合酪氨酸1068/1086磷酸化的EGFR以激活Arf6。GEP100与Arf6一起过表达会使非侵袭性MCF7细胞变得具有侵袭性,这依赖于EGF刺激。此外,GEP100基因敲低可阻断肿瘤转移。GEP100在70%的原发性乳腺导管癌中表达,并且在恶性病例中优先与EGFR共表达。我们的结果表明,GEP100将EGFR信号传导与Arf6激活联系起来,以诱导某些乳腺癌细胞的侵袭活性,因此可能促成它们的转移和恶性程度。

相似文献

1
GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion.GEP100将表皮生长因子受体信号传导与Arf6激活相联系,以诱导乳腺癌侵袭。
Nat Cell Biol. 2008 Jan;10(1):85-92. doi: 10.1038/ncb1672. Epub 2007 Dec 16.
2
The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis.表皮生长因子受体-GEP100-Arf6-AMAP1信号通路特异性参与乳腺癌侵袭和转移。
Traffic. 2009 Aug;10(8):982-93. doi: 10.1111/j.1600-0854.2009.00917.x. Epub 2009 Apr 21.
3
The EGFR-GEP100-Arf6 pathway in breast cancer: Full invasiveness is not from the inside.乳腺癌中的表皮生长因子受体-鸟嘌呤核苷酸交换蛋白100-腺嘌呤核苷释放因子6通路:完全侵袭性并非源于内部。
Cell Adh Migr. 2008 Apr-May;2(2):71-3. doi: 10.4161/cam.2.2.6191. Epub 2008 Apr 23.
4
GEP100 regulates epidermal growth factor-induced MDA-MB-231 breast cancer cell invasion through the activation of Arf6/ERK/uPAR signaling pathway.GEP100 通过激活 Arf6/ERK/uPAR 信号通路调节表皮生长因子诱导的 MDA-MB-231 乳腺癌细胞侵袭。
Exp Cell Res. 2013 Aug 1;319(13):1932-1941. doi: 10.1016/j.yexcr.2013.05.028. Epub 2013 Jun 5.
5
Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.AMAP1 在细胞侵袭中作为 Arf6 的效应物频繁过表达,这是 MMTV-PyMT 而非 MMTV-Neu 人乳腺癌模型的特征。
Cell Commun Signal. 2018 Jan 5;16(1):1. doi: 10.1186/s12964-017-0212-z.
6
GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis.GEP100-Arf6-AMAP1-cortactin 通路在癌症侵袭中经常被激活,该通路由 VEGFR2 激活以促进血管生成。
PLoS One. 2011;6(8):e23359. doi: 10.1371/journal.pone.0023359. Epub 2011 Aug 15.
7
GEP100/Arf6 is required for epidermal growth factor-induced ERK/Rac1 signaling and cell migration in human hepatoma HepG2 cells.GEP100/Arf6 对于表皮生长因子诱导的 ERK/Rac1 信号通路和人肝癌 HepG2 细胞的迁移是必需的。
PLoS One. 2012;7(6):e38777. doi: 10.1371/journal.pone.0038777. Epub 2012 Jun 11.
8
Epidermal growth factor receptor-GEP100-Arf6 axis affects the prognosis of lung adenocarcinoma.表皮生长因子受体-GEP100-Arf6轴影响肺腺癌的预后。
Oncology. 2014;86(5-6):263-70. doi: 10.1159/000360089. Epub 2014 Jun 4.
9
Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation.表皮生长因子诱导的胶质母细胞瘤细胞增殖需要二磷酸腺苷核糖基化因子6 。
Cancer. 2009 Nov 1;115(21):4959-72. doi: 10.1002/cncr.24550.
10
Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.Y盒结合蛋白1赋予人乳腺上皮细胞对表皮生长因子的非依赖性。
Oncogene. 2005 Apr 28;24(19):3177-86. doi: 10.1038/sj.onc.1208504.

引用本文的文献

1
ArfGAP with the SH3 Domain, Ankyrin Repeat and PH Domain 1 Inversely Regulates Programmed Death-Ligand 1 Through Negative Feedback of Phosphorylated Epithelial Growth Factor Receptor and Activation of Nuclear Factor-Kappa B in Non-Small Cell Lung Cancer.含SH3结构域、锚蛋白重复序列和PH结构域的ArfGAP 1通过磷酸化表皮生长因子受体的负反馈和非小细胞肺癌中核因子-κB的激活反向调节程序性死亡配体1
Cancer Manag Res. 2025 Jan 20;17:91-102. doi: 10.2147/CMAR.S493368. eCollection 2025.
2
Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives.胰腺癌中的可塑性与肿瘤微环境:遗传学、代谢及免疫视角
Cancers (Basel). 2024 Dec 6;16(23):4094. doi: 10.3390/cancers16234094.
3
Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapy.
ARF6 介导的肿瘤内在内膜运输塑造了免疫抑制微环境,促进了黑色素瘤的发生发展以及对检查点阻断治疗的反应。
Nat Commun. 2024 Aug 4;15(1):6613. doi: 10.1038/s41467-024-50881-1.
4
Association of ADP‑ribosylation factor family genes with prognosis and immune infiltration of breast cancer.ADP-核糖基化因子家族基因与乳腺癌预后及免疫浸润的关联
Oncol Lett. 2024 Apr 23;27(6):280. doi: 10.3892/ol.2024.14413. eCollection 2024 Jun.
5
Membrane trafficking alterations in breast cancer progression.乳腺癌进展过程中的膜转运改变。
Front Cell Dev Biol. 2024 Mar 12;12:1350097. doi: 10.3389/fcell.2024.1350097. eCollection 2024.
6
VNP20009-Abvec-Igκ-MIIP suppresses ovarian cancer progression by modulating Ras/MEK/ERK signaling pathway.VNP20009-Abvec-Igκ-MIIP 通过调节 Ras/MEK/ERK 信号通路抑制卵巢癌进展。
Appl Microbiol Biotechnol. 2024 Feb 19;108(1):218. doi: 10.1007/s00253-024-13047-z.
7
ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancer.依赖ARF6的干扰素-γ受体胞吞运输驱动癌症中的适应性免疫抵抗。
bioRxiv. 2023 Oct 2:2023.09.29.560199. doi: 10.1101/2023.09.29.560199.
8
ADP-Ribosylation Factor 6 Pathway Acts as a Key Executor of Mesenchymal Tumor Plasticity.ADP核糖基化因子6通路是间充质肿瘤可塑性的关键执行者。
Int J Mol Sci. 2023 Oct 5;24(19):14934. doi: 10.3390/ijms241914934.
9
ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling.ARF6通过激活STAT3信号通路促进肝细胞癌增殖。
Cancer Cell Int. 2023 Sep 16;23(1):205. doi: 10.1186/s12935-023-03053-y.
10
Endocytosis in cancer and cancer therapy.癌症和癌症治疗中的内吞作用。
Nat Rev Cancer. 2023 Jul;23(7):450-473. doi: 10.1038/s41568-023-00574-6. Epub 2023 May 22.